Vera Buerger

767 total citations · 1 hit paper
12 papers, 488 citations indexed

About

Vera Buerger is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Vera Buerger has authored 12 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Vera Buerger's work include Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (7 papers) and Viral Infections and Outbreaks Research (4 papers). Vera Buerger is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (7 papers) and Viral Infections and Outbreaks Research (4 papers). Vera Buerger collaborates with scholars based in Austria, United States and Italy. Vera Buerger's co-authors include Christoph Klade, Erich Tauber, Sandra Jelovcan, Michael Buschle, Christa Firbas, Bernd Jilma, Karen Lingnau, Jürgen Frisch, Elisabeth Schuller and Katrin Dubischar and has published in prestigious journals such as The Lancet, Gastroenterology and The Lancet Infectious Diseases.

In The Last Decade

Vera Buerger

10 papers receiving 468 citations

Hit Papers

Safety and immunogenicity of a single-shot live-attenuate... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
    2023 94 citations Martina Schneider, Robert P. McMahon et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Buerger Austria 8 233 198 194 191 88 12 488
Kenn Forberg United States 10 165 0.7× 136 0.7× 94 0.5× 186 1.0× 45 0.5× 19 426
Trevor Barnes United States 9 240 1.0× 392 2.0× 79 0.4× 337 1.8× 109 1.2× 10 637
Reinhard Glueck Switzerland 12 316 1.4× 172 0.9× 87 0.4× 72 0.4× 73 0.8× 19 485
Lucile Warter United States 12 161 0.7× 360 1.8× 63 0.3× 425 2.2× 103 1.2× 21 688
Jennifer M. Pfaff United States 16 246 1.1× 462 2.3× 185 1.0× 330 1.7× 133 1.5× 18 833
María Pirón Spain 16 578 2.5× 220 1.1× 367 1.9× 330 1.7× 99 1.1× 34 951
Michelle Walker United States 13 285 1.2× 302 1.5× 235 1.2× 133 0.7× 150 1.7× 16 616
Lawrence D. Loomis‐Price United States 10 182 0.8× 132 0.7× 175 0.9× 37 0.2× 68 0.8× 15 469
Bruce J. Dille United States 9 296 1.3× 126 0.6× 211 1.1× 109 0.6× 35 0.4× 13 465
Marcy E. Armstrong United States 8 318 1.4× 155 0.8× 106 0.5× 31 0.2× 132 1.5× 8 468

Countries citing papers authored by Vera Buerger

Since Specialization
Citations

This map shows the geographic impact of Vera Buerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Buerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Buerger more than expected).

Fields of papers citing papers by Vera Buerger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Buerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Buerger. The network helps show where Vera Buerger may publish in the future.

Co-authorship network of co-authors of Vera Buerger

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Buerger. A scholar is included among the top collaborators of Vera Buerger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Buerger. Vera Buerger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kosulin, Karin, Trevor Brasel, Jeanon N. Smith, et al.. (2025). Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages. Emerging Microbes & Infections. 14(1). 2469653–2469653. 1 indexed citations
2.
3.
4.
McMahon, Robert P., Martina Schneider, Romana Hochreiter, et al.. (2024). Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study. The Lancet Infectious Diseases. 24(12). 1383–1392. 15 indexed citations
5.
Buerger, Vera, Gerald Maurer, Karin Kosulin, et al.. (2024). Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine. Journal of Travel Medicine. 31(7). 7 indexed citations
6.
Maurer, Gerald, et al.. (2024). Pooled safety evaluation for a new single-shot live-attenuated chikungunya vaccine. Journal of Travel Medicine. 31(8). 6 indexed citations
7.
Schneider, Martina, Robert P. McMahon, Ulrike Fuchs, et al.. (2023). Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet. 401(10394). 2138–2147. 94 indexed citations breakdown →
8.
9.
Firbas, Christa, Thomas Boehm, Vera Buerger, et al.. (2010). Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine. Vaccine. 28(12). 2397–2407. 45 indexed citations
10.
Dubischar-Kastner, Katrin, Susanne Eder, Vera Buerger, et al.. (2010). Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51. Vaccine. 28(32). 5197–5202. 45 indexed citations
11.
Klade, Christoph, Heiner Wedemeyer, Thomas Berg, et al.. (2008). Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41. Gastroenterology. 134(5). 1385–1395.e1. 123 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenn Forberg Breakdown of academic impact, for papers by Trevor Barnes Breakdown of academic impact, for papers by Reinhard Glueck Breakdown of academic impact, for papers by Lucile Warter Breakdown of academic impact, for papers by Jennifer M. Pfaff Breakdown of academic impact, for papers by María Pirón Breakdown of academic impact, for papers by Michelle Walker Breakdown of academic impact, for papers by Lawrence D. Loomis‐Price Breakdown of academic impact, for papers by Bruce J. Dille Breakdown of academic impact, for papers by Marcy E. Armstrong
Rankless by CCL
2026